Report Detail
Global (United States, European Union and China) Japanese Encephalitis (JE) Vaccine Market Research Report 2019-2025
- RnM3648083 |
- 06 August, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. How long this protection lasts is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.
It is recommended as part of routine immunizations in countries where the disease is a problem. One or two doses are given depending on the version of the vaccine. Extra doses are not typically needed in areas where the disease is common. In those with HIV/AIDS or those who are pregnant an inactivated vaccine should be used. Immunization of travellers who plan to spend time outdoors in areas where the disease is common is recommended.
In 2019, the market size of Japanese Encephalitis (JE) Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Japanese Encephalitis (JE) Vaccine.
This report studies the global market size of Japanese Encephalitis (JE) Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Japanese Encephalitis (JE) Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
GSK
Sanofi
Chengdu institute of biologica
Wuhan Institute of Biological
Lanzhou Institute of Biological
Beijing Taitan
Valneva
Bharat Biotech
Biological E. Limited
Liaoning Chengda
Market Segment by Product Type
Inactivated Vaccine
Live Attenuated Vaccine
Market Segment by Application
Public
Private
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Japanese Encephalitis (JE) Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Japanese Encephalitis (JE) Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Japanese Encephalitis (JE) Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Inactivated Vaccine
- 1.3.3 Live Attenuated Vaccine
- 1.4 Market Segment by Application
- 1.4.1 Global Japanese Encephalitis (JE) Vaccine Market Share by Application (2019-2025)
- 1.4.2 Public
- 1.4.3 Private
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Japanese Encephalitis (JE) Vaccine Market Size
- 2.1.1 Global Japanese Encephalitis (JE) Vaccine Revenue 2014-2025
- 2.1.2 Global Japanese Encephalitis (JE) Vaccine Sales 2014-2025
- 2.2 Japanese Encephalitis (JE) Vaccine Growth Rate by Regions
- 2.2.1 Global Japanese Encephalitis (JE) Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Japanese Encephalitis (JE) Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers
- 3.1.1 Japanese Encephalitis (JE) Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Japanese Encephalitis (JE) Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Japanese Encephalitis (JE) Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Japanese Encephalitis (JE) Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Japanese Encephalitis (JE) Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Japanese Encephalitis (JE) Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Japanese Encephalitis (JE) Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Japanese Encephalitis (JE) Vaccine Market
- 3.6 Key Manufacturers Japanese Encephalitis (JE) Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Inactivated Vaccine Sales and Revenue (2014-2019)
- 4.1.2 Live Attenuated Vaccine Sales and Revenue (2014-2019)
- 4.2 Global Japanese Encephalitis (JE) Vaccine Sales Market Share by Type
- 4.3 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Type
- 4.4 Japanese Encephalitis (JE) Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Japanese Encephalitis (JE) Vaccine Sales by Application
6 United States
- 6.1 United States Japanese Encephalitis (JE) Vaccine Breakdown Data by Company
- 6.2 United States Japanese Encephalitis (JE) Vaccine Breakdown Data by Type
- 6.3 United States Japanese Encephalitis (JE) Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Japanese Encephalitis (JE) Vaccine Breakdown Data by Company
- 7.2 European Union Japanese Encephalitis (JE) Vaccine Breakdown Data by Type
- 7.3 European Union Japanese Encephalitis (JE) Vaccine Breakdown Data by Application
8 China
- 8.1 China Japanese Encephalitis (JE) Vaccine Breakdown Data by Company
- 8.2 China Japanese Encephalitis (JE) Vaccine Breakdown Data by Type
- 8.3 China Japanese Encephalitis (JE) Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Japanese Encephalitis (JE) Vaccine Breakdown Data by Company
- 9.2 Rest of World Japanese Encephalitis (JE) Vaccine Breakdown Data by Type
- 9.3 Rest of World Japanese Encephalitis (JE) Vaccine Breakdown Data by Application
- 9.4 Rest of World Japanese Encephalitis (JE) Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Japanese Encephalitis (JE) Vaccine Sales by Countries
- 9.4.2 Rest of World Japanese Encephalitis (JE) Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 GSK
- 10.1.1 GSK Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.1.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.1.5 GSK Recent Development
- 10.2 Sanofi
- 10.2.1 Sanofi Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.2.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.2.5 Sanofi Recent Development
- 10.3 Chengdu institute of biologica
- 10.3.1 Chengdu institute of biologica Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.3.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.3.5 Chengdu institute of biologica Recent Development
- 10.4 Wuhan Institute of Biological
- 10.4.1 Wuhan Institute of Biological Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.4.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.4.5 Wuhan Institute of Biological Recent Development
- 10.5 Lanzhou Institute of Biological
- 10.5.1 Lanzhou Institute of Biological Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.5.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.5.5 Lanzhou Institute of Biological Recent Development
- 10.6 Beijing Taitan
- 10.6.1 Beijing Taitan Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.6.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.6.5 Beijing Taitan Recent Development
- 10.7 Valneva
- 10.7.1 Valneva Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.7.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.7.5 Valneva Recent Development
- 10.8 Bharat Biotech
- 10.8.1 Bharat Biotech Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.8.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.8.5 Bharat Biotech Recent Development
- 10.9 Biological E. Limited
- 10.9.1 Biological E. Limited Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.9.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.9.5 Biological E. Limited Recent Development
- 10.10 Liaoning Chengda
- 10.10.1 Liaoning Chengda Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Japanese Encephalitis (JE) Vaccine
- 10.10.4 Japanese Encephalitis (JE) Vaccine Product Introduction
- 10.10.5 Liaoning Chengda Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Japanese Encephalitis (JE) Vaccine Sales Channels
- 11.2.2 Japanese Encephalitis (JE) Vaccine Distributors
- 11.3 Japanese Encephalitis (JE) Vaccine Customers
12 Market Forecast
- 12.1 Global Japanese Encephalitis (JE) Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Type
- 12.3 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Application
- 12.4 Japanese Encephalitis (JE) Vaccine Forecast by Regions
- 12.4.1 Global Japanese Encephalitis (JE) Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Japanese Encephalitis (JE) Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Japanese Encephalitis (JE) Vaccine. Industry analysis & Market Report on Japanese Encephalitis (JE) Vaccine is a syndicated market report, published as Global (United States, European Union and China) Japanese Encephalitis (JE) Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Japanese Encephalitis (JE) Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
